Portfolio company
Acurx Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SelectX Pharmaceuticals
This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.
C10 PHARMA
This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.
Omnix Medical
This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.
Calixa Therapeutics
This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.
Paratek
This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.
Nabriva
This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.
Adjutecpharma
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
Iterum Therapeutics
This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.
